Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.026 | 0.8 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0096 | 0.9 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |